Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $581.54 million. The enterprise value is $554.61 million.
Important Dates
The last earnings date was Wednesday, May 27, 2026, before market open.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | May 29, 2026 |
Share Statistics
MLAB has 5.52 million shares outstanding. The number of shares has increased by 2.66% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +2.66% |
| Shares Change (QoQ) | -0.38% |
| Owned by Insiders (%) | 3.22% |
| Owned by Institutions (%) | 87.82% |
| Float | 4.94M |
Valuation Ratios
The trailing PE ratio is 86.99 and the forward PE ratio is 77.40.
| PE Ratio | 86.99 |
| Forward PE | 77.40 |
| PS Ratio | 2.33 |
| Forward PS | 2.17 |
| PB Ratio | 3.13 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 82.63 |
| EV / Sales | 2.23 |
| EV / EBITDA | 13.25 |
| EV / EBIT | 29.96 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.88% and return on invested capital (ROIC) is 4.26%.
| Return on Equity (ROE) | 3.88% |
| Return on Assets (ROA) | 2.69% |
| Return on Invested Capital (ROIC) | 4.26% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 9.42% |
| Revenue Per Employee | $341,274 |
| Profits Per Employee | $9,195 |
| Employee Count | 730 |
| Asset Turnover | 0.58 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MLAB has paid $5.30 million in taxes.
| Income Tax | 5.30M |
| Effective Tax Rate | 44.13% |
Stock Price Statistics
The stock price has increased by +4.61% in the last 52 weeks. The beta is 0.94, so MLAB's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | +4.61% |
| 50-Day Moving Average | 97.41 |
| 200-Day Moving Average | 82.66 |
| Relative Strength Index (RSI) | 54.28 |
| Average Volume (20 Days) | 172,350 |
Short Selling Information
The latest short interest is 232,139, so 4.20% of the outstanding shares have been sold short.
| Short Interest | 232,139 |
| Short Previous Month | 198,615 |
| Short % of Shares Out | 4.20% |
| Short % of Float | 4.70% |
| Short Ratio (days to cover) | 1.90 |
Income Statement
In the last 12 months, MLAB had revenue of $249.13 million and earned $6.71 million in profits. Earnings per share was $1.21.
| Revenue | 249.13M |
| Gross Profit | 158.27M |
| Operating Income | 18.51M |
| Pretax Income | 12.01M |
| Net Income | 6.71M |
| EBITDA | 41.87M |
| EBIT | 18.51M |
| Earnings Per Share (EPS) | $1.21 |
Full Income Statement Balance Sheet
The company has $26.93 million in cash and n/a in debt, with a net cash position of $26.93 million or $4.87 per share.
| Cash & Cash Equivalents | 26.93M |
| Total Debt | n/a |
| Net Cash | 26.93M |
| Net Cash Per Share | $4.87 |
| Equity (Book Value) | 186.25M |
| Book Value Per Share | 33.59 |
| Working Capital | 106.27M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 23.36M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 63.53%, with operating and profit margins of 7.43% and 2.69%.
| Gross Margin | 63.53% |
| Operating Margin | 7.43% |
| Pretax Margin | 4.82% |
| Profit Margin | 2.69% |
| EBITDA Margin | 16.81% |
| EBIT Margin | 7.43% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.63%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.63% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 52.89% |
| Buyback Yield | -2.66% |
| Shareholder Yield | -2.05% |
| Earnings Yield | 1.15% |
| FCF Yield | n/a |
Dividend Details Analyst Forecast
The average price target for MLAB is $112.00, which is 6.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $112.00 |
| Price Target Difference | 6.40% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |